📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Avidity Biosciences Inc

Common Name
Avidity Biosciences
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
391
Ticker
RNA
Exchange
NASDAQ/NMS
Description
Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligon...

Avidity Biosciences's Financial Statements Preview

Below are the financial statements of Avidity Biosciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Collaboration revenue
10.9a
9.56a
9.22a
Operating expenses———
Research and development
-303.59a
-190.97a
-150.4a
General and administrative
-86.24a
-54.19a
-37.73a
Total operating expenses
-389.83a
-245.16a
-188.14a
Loss from operations
-378.94a
-235.6a
-178.91a
Other income (expense)———
Interest income
56.88a
23.97a
4.98a
Other expense
-0.25a
-0.59a
-0.06a
Total other income
56.63a
23.38a
4.92a
Net loss
-322.3a
-212.22a
-174a
Download Data

Verified Sources Behind Avidity Biosciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Avidity Biosciences’s data sources below and access millions more through our Disclosure Search.

a. Avidity Biosciences's 10-K 2024
a. Avidity Biosciences's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?